Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on euronews

This article delves into the pros and cons of these drugs, addressing potential side effects (including the rare ones).

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order through Zeullig Pharma Korea.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years.

Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given as regular injections, the treatments – Wegovy and Mounjaro – mimic a hormone that makes people less hungry.

Sky News has revealed thousands of people with severe obesity are being denied access to effective treatment, partly because of a slow NHS rollout of the weight loss jab Wegovy.